来源：市场资讯 （来源：明见局） 此前创始人李天天曾透露公司年利润有40%-50%增长，但业务模式还未跑通，如今三年过去，其业务模 式是否成熟完善有待招股书披露。 近日，国内知名互联网医疗内容平台丁香园再度传出上市消息，最快或于年内递交港股招股书。 这已是丁香园自成立以来第三次被传冲刺IPO，而此前两次公司均以"暂无明确时间表"予以否认。 公开资料显示，丁香园成立于2000年7月，是中国领先的数字医疗健康科技企业，通过专业权威的内容 分享互动、丰富全面的医疗数据积累、高质量的数字医疗服务，连接医生、患众、医院、生物医药企 业、科研企业和大众消费品企业等。 不卖药的丁香园，获挚信、高瓴、腾讯参投 回溯到2000年，哈尔滨医科大学的研究生李天天，正被医学文献检索的难题所困扰，在求知若渴的驱动 下，他自学建站后推出了"丁香园医学文献检索网"。 丁香园发挥专业论坛的内容优势，邀请行业专家进行科普投稿，用通俗易懂的语言向大众传递科学的医 疗认知，积极辟谣打假各类医学谣言，成为了大众健康知识的"把关人"。 "丁香医生"公众号也因此迅速出圈，之后衍生出了"丁香系"IP矩阵，涵盖了多个垂直领域，为不同需求 的用户提供全方位的 ...

Core Viewpoint - DXY (Dingxiangyuan), a digital healthcare technology company, is preparing for an IPO in Hong Kong, with plans to submit its prospectus to the Hong Kong Stock Exchange by the end of this year [1]. Company Overview - Founded in July 2000 by Li Tiantian, DXY started as a BBS forum aimed at providing a professional communication platform for the pharmaceutical and life sciences sectors. It has since evolved into a comprehensive platform connecting doctors, patients, hospitals, and biopharmaceutical companies [1]. - DXY has served over 100 million general users and has more than 9 million professional users, accounting for 80% of national health technicians, including over 4.05 million doctors, with a coverage rate exceeding 90% [1]. Product Offerings - For professional doctors, DXY offers products such as "Medication Assistant" (a drug information query tool), DXY Insight (pharmaceutical policy and market information), and DXY Talent (medical professional recruitment) [1]. - For general users, DXY provides services through "DXY Doctor" (health science popularization and online consultation), "DXY Mama" (maternal and child health), and DXY Life Research Institute (health consumption guide), utilizing articles, videos, and online consultations [1]. Business Model - In 2016, DXY opened its first offline clinic in Hangzhou, exploring a retail model for medical services, focusing on service rather than merely prescribing medication, with a goal to keep the drug proportion below 20% [4]. - The clinic primarily serves patients with common ailments such as colds, fevers, and minor injuries, positioning itself similarly to community health service centers, distinguishing itself from large hospitals [4]. Investment and Funding - DXY has attracted investments from notable venture capital firms, including DCM Ventures, Shunwei Capital, Tencent, Zhi Xin Capital, and Hillhouse Capital [5].

Group 1 - The core point of the article is that the digital healthcare technology company "Dingxiangyuan" is preparing for an IPO in Hong Kong, with plans to submit its prospectus to the Hong Kong Stock Exchange as early as this year [1] - Dingxiangyuan was established in July 2000 and serves a vast user base, boasting 9 million registered professional users, which accounts for 80% of the national healthcare technical personnel, including 4.05 million registered physician users, representing 92% of the total practicing physicians in the country [1] - The company offers various health application scenarios, including health science popularization, public knowledge services, online consultation platforms, and health product e-commerce, and has developed multiple sub-brands such as Dingxiang Doctor, Dingxiang Mama, and Dingxiang Home [1] Group 2 - On the professional side, Dingxiangyuan focuses on the career development of doctors, addressing multiple professional needs such as academic exchange, continuing education, medication guidance, and career development, and has created well-known products in the medical field like Medication Assistant, Dingxiang Insight, Dingxiang Talent, and Dingxiang Open Class [1] - Since its inception, Dingxiangyuan has received investments from well-known institutions including DCM, Shunwei Capital, Tencent, Zhi Xin Capital, and Hillhouse Capital [2]

Group 1 - The core point of the article is that the digital healthcare technology company "Dingxiangyuan" is preparing for an IPO in Hong Kong, with plans to submit its prospectus to the Hong Kong Stock Exchange as early as this year [1] - Dingxiangyuan was established in July 2000 and serves a vast user base, boasting 9 million registered professional users, which accounts for 80% of the national healthcare technical personnel, including 4.05 million registered physician users, representing 92% of the total practicing physicians in the country [1] - The company offers various health application scenarios, including health science popularization, public knowledge services, online consultation platforms, and health product e-commerce, and has developed multiple sub-brands such as Dingxiang Doctor, Dingxiang Mama, and Dingxiang Home [1] Group 2 - On the professional side, Dingxiangyuan focuses on the career development of doctors, addressing multiple professional needs such as academic exchange, continuing education, medication guidance, and career development, and has created well-known products in the medical field like Medication Assistant, Dingxiang Insight, Dingxiang Talent, and Dingxiang Open Class [1] - Since its inception, Dingxiangyuan has attracted investments from renowned institutions including DCM, Shunwei Capital, Tencent, Zhi Xin Capital, and Hillhouse Capital [2]